| Literature DB >> 35685284 |
Alain Riveros-Rivera1,2, Thomas Penzel3, Hanns-Christian Gunga1, Oliver Opatz1, Friedemann Paul4,5,6, Lars Klug4,5,6, Michael Boschmann4,5,6, Anja Mähler4,5,6,7.
Abstract
Context: The use of daytime napping as a countermeasure in sleep disturbances has been recommended but its physiological evaluation at high altitude is limited. Objective: To evaluate the neuroendocrine response to hypoxic stress during a daytime nap and its cognitive impact. Design, Subject, and Setting: Randomized, single-blind, three period cross-over pilot study conducted with 15 healthy lowlander subjects (8 women) with a mean (SD) age of 29(6) years (Clinicaltrials identifier: NCT04146857, https://clinicaltrials.gov/ct2/show/NCT04146857?cond=napping&draw=3&rank=12). Interventions: Volunteers underwent a polysomnography, hematological and cognitive evaluation around a 90 min midday nap, being allocated to a randomized sequence of three conditions: normobaric normoxia (NN), normobaric hypoxia at FiO2 14.7% (NH15) and 12.5% (NH13), with a washout period of 1 week between conditions.Entities:
Keywords: autonomic nervous system; high altitude (low air pressure); hypoxia; napping; physiological stress; sleep
Year: 2022 PMID: 35685284 PMCID: PMC9171024 DOI: 10.3389/fphys.2022.899636
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1CONSORT 2010 flow diagram (A) and study protocol (B).
Anthropometric and hematologic parameters of 15 healthy men and women. Data as mean ± SD.
| Women (8) | Men (7) | All (15) | Sex difference p-value ( | |
|---|---|---|---|---|
| Age (years) | 26.5 ± 3.2 | 32.6 ± 8.1 | 29.3 ± 6.6 | 0.07 |
| Mass (kg) | 61.1 ± 4.7 | 81.9 ± 8.4 | 70.8 ± 12.5 | <0.001 |
| Height (cm) | 167 ± 5.0 | 182 ± 9.8 | 174 ± 10.8 | 0.002 |
| Body Mass Index (kg/m2) | 22.0 ± 1.7 | 24.8 ± 2.8 | 23.3 ± 2.6 | 0.034 |
| Fat Mass (%) | 28.3 ± 4.3 | 22.1 ± 5.0 | 25.4 ± 5.5 | 0.023 |
| Fat Free Mass (%) | 71.7 ± 4.3 | 77.9 ± 5.0 | 74.6 ± 5.5 | 0.023 |
| Body Water% | 50.4 ± 3.5 | 57.1 ± 4.0 | 53.5 ± 5.0 | 0.004 |
| Erythrocytes/pL | 4.31 ± 0.2 | 5.13 ± 0.4 | 4.69 ± 0.5 | <0.001 |
| Hemoglobin (g/dl) | 12.8 ± 0.7 | 15.2 ± 0.8 | 13.9 ± 1.4 | <0.001 |
| Hematocrit (%) | 38.5 ± 1.9 | 45.0 ± 2.8 | 41.5 ± 4.0 | <0.001 |
Heart rate variability parameters during a daytime nap in normobaric normoxia (NN) and normobaric hypoxia (NH15: FiO2 14.7, NH13: FiO2 12.5).
| Phase | N | RR (ms) | RMSSD (ms) | SD1 (ms) | PNS | HR (b.p.m.) | SD2 (ms) | SI | SNS | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NN | Women | Pre | 8 | 985 ± 115 | 66.3 ± 48 | 47 ± 34 | 1 ± 1.84 | 61.6 ± 7.1 | 64.3 ± 25.7 | 8.2 ± 2.7 | −0.52 ± 0.92 |
| N2 | 8 | 1,024 ± 146 | 74.9 ± 43 | 53 ± 30 | 1.44 ± 1.79 | 59.8 ± 9.4 | 64.4 ± 14.8 | 7.8 ± 3.3 | −0.73 ± 1.16 | ||
| Pos | 8 | 938 ± 125 | 56.7 ± 46 | 40 ± 33 | 0.55 ± 1.81 | 65 ± 8.9 | 50.2 ± 22.1 | 10.8 ± 4 | 0.08 ± 1.21 | ||
| Men | Pre | 7 | 1,172 ± 170 | 55 ± 34 | 39 ± 24 | 1.54 ± 1.76 | 52.1 ± 6.9 | 52.6 ± 15.7 | 8.7 ± 3.9 | −1.05 ± 1.13 | |
| N2 | 7 | 1,230 ± 157 | 48.7 ± 24 | 35 ± 17 | 1.64 ± 1.32 | 49.4 ± 5.5 | 49.1 ± 19.6 | 8.5 ± 2.7 | −1.26 ± 0.75 | ||
| Pos | 7 | 1,083 ± 95 | 42.8 ± 21 | 30 ± 15 | 0.77 ± 0.97 | 55.8 ± 5 | 54 ± 23.3 | 9.5 ± 3.7 | −0.65 ± 0.74 | ||
| All | Pre | 15 | 1,072 ± 168 | 61 ± 41.2 | 43.2 ± 29.2 | 1.25 ± 1.76 | 57.2 ± 8.4 | 58.8 ± 21.8 | 8.4 ± 3.2 | −0.77 ± 1.02 | |
| N2 | 15 | 1,120 ± 180 | 62.7 ± 36.6 | 44.4 ± 26 | 1.53 ± 1.54 | 54.9 ± 9.3 | 57.3 ± 18.4 | 8.1 ± 2.9 | −0.98 ± 1 | ||
| Pos | 15 | 1,006 ± 132 | 50.2 ± 36.2 | 35.6 ± 25.6 | 0.65 ± 1.43 | 60.7 ± 8.5 | 52 ± 21.9 | 10.2 ± 3.8 | −0.26 ± 1.05 | ||
| NH15 | Women | Pre | 8 | 876 ± 122 | 42.1 ± 21 | 30 ± 15 | 0.25 ± 1.75 | 69.6 ± 9.1* | 61.8 ± 28.9 | 9 ± 3.4 | 0.15 ± 1.02 |
| N2 | 7m | 940 ± 165 | 64.7 ± 43 | 46 ± 30 | 0.75 ± 1.91 | 65.6 ± 11.4 | 62.3 ± 23.4 | 9.4 ± 4.5 | −0.07 ± 1.5 | ||
| Pos | 7m | 795 ± 109* | 26.6 ± 17 | 19 ± 12 | −1 ± 0.94* | 76.6 ± 9.6** | 37.8 ± 18.9 | 15.2 ± 6.5 | 1.61 ± 1.6*A | ||
| Men | Pre | 6m | 1,135 ± 185 | 53.8 ± 37 | 38 ± 26 | 1.28 ± 1.88 | 53.9 ± 8.2 | 63.6 ± 19.2 | 7.7 ± 2.5 | −1.02 ± 0.94 | |
| N2 | 6m | 1207 ± 123 | 51.7 ± 28 | 37 ± 20 | 1.54 ± 1.37 | 50.1 ± 4.7 | 67.9 ± 26.9 | 7.6 ± 2.7 | −1.28 ± 0.68 | ||
| Pos | 6m | 1,036 ± 86 | 38.3 ± 25 | 27 ± 18 | 0.4 ± 1.03 | 58.3 ± 5.3 | 55.7 ± 26.6 | 10.4 ± 4.7 | −0.31 ± 0.85 | ||
| All | Pre | 13 | 987 ± 197* | 47.5 ± 28.9 | 33.7 ± 20.5 | 0.69 ± 1.81 | 62.9 ± 11.6* | 62.6 ± 24.3 | 8.4 ± 3 | −0.36 ± 1.13 | |
| N2 | 13 | 1,063 ± 198 | 58.7 ± 35.7 | 41.6 ± 25.3 | 1.12 ± 1.67 | 58.4 ± 11.8 | 64.9 ± 24.2 | 8.6 ± 3.7 | −0.63 ± 1.31 | ||
| Pos | 13 | 906 ± 157**A | 32 ± 20.7 | 22.7 ± 14.6 | −0.36 ± 1.19*A | 68.2 ± 12.2*A | 46.1 ± 23.7 | 13 ± 6 | 0.73 ± 1.6A | ||
| NH13 | Women | Pre | 8 | 781 ± 85** | 30.5 ± 17 | 22 ± 12* | −0.96 ± 0.81** | 77.5 ± 7.9** | 43.9 ± 15.8 | 13.4 ± 4.5 | 1.4 ± 1.14** |
| N2 | 8 | 797 ± 168** | 36.8 ± 32 | 26 ± 23* | −0.73 ± 1.64** | 78.2 ± 16** | 48.4 ± 31.4 | 16.6 ± 12.5* | 1.97 ± 2.96** | ||
| Pos | 8 | 708 ± 93** | 15.7 ± 11 | 11 ± 8* | −1.77 ± 0.77** | 86 ± 10.7**A | 31.3 ± 17.5 | 19.3 ± 7.1* | 2.95 ± 1.61**A | ||
| Men | Pre | 7 | 1,010 ± 126** | 46.8 ± 28* | 33 ± 20 | 0.45 ± 1.29 | 60.2 ± 7.1 | 81 ± 41.8 | 7.7 ± 2.6 | −0.55 ± 0.82 | |
| N2 | 7 | 1,048 ± 103** | 52.3 ± 32* | 37 ± 22 | 0.77 ± 1.31 | 57.7 ± 5.2* | 93 ± 45.6* | 7 ± 3.5 | −0.81 ± 0.78 | ||
| Pos | 7 | 909 ± 50** | 27.3 ± 14* | 19 ± 10 | −0.55 ± 0.59 | 66.2 ± 3.7* | 54.3 ± 18.8 | 10.8 ± 4 | 0.34 ± 0.74 | ||
| All | Pre | 15 | 888 ± 156** | 38.1 ± 23.3* | 27 ± 16.5* | −0.3 ± 1.26** | 69.4 ± 11.6** | 61.2 ± 35.2 | 10.8 ± 4.7 | 0.49 ± 1.39* | |
| N2 | 15 | 914 ± 188** | 44 ± 31.7 | 31.2 ± 22.5 | −0.03 ± 1.64** | 68.6 ± 15.9** | 69.2 ± 43.8 | 12.1 ± 10.4 | 0.67 ± 2.59** | ||
| Pos | 15 | 802 ± 127**A | 21.1 ± 13.5* | 15 ± 9.6* | −1.2 ± 0.92*A | 76.7 ± 12.9**B | 42 ± 21.1 | 15.4 ± 7.2* | 1.73 ± 1.83**A | ||
mMissing data due to lack of sleep or ECG artifacts. Data as mean ± SD. *p <0.05, **p <0.001 comparing the same phase with NN. A p <0.05, B p <0.001 comparing with pre in the same condition (Linear Mixed Model).
FIGURE 2Correlations of after nap stress hormone levels (EPO, cortisol, norepinephrine) with HRV parameters measured after, during and after the nap. Positive correlations are displayed in light gray and negative correlations in dark gray. Circle size and intensity are proportional to the correlation coefficients. *p < 0.05 (Pearson’s r).
Main polysomnography parameters during a daytime nap in normobaric normoxia (NN) and normobaric hypoxia (NH15: FiO2 14.7, NH13: FiO2 12.5).
| N | TST (min) | WASO (min) | SPT (min) | SOL (min) | N1 %TST | N2 %TST | N3 %TST | SE TST | SE SPT | % SpO2 TST | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NH | Women | 8 | 68.3 ± 21 | 21 ± 24.6 | 87.4 ± 7.4 | 3.9 ± 5.8 | 24 ± 22.1 | 39.8 ± 11.5 | 30.6 ± 20.4 | 74.7 ± 25.7 | 94 ± 7.6 | 96.1 ± 1.6 |
| Men | 7 | 71.5 ± 18.3 | 15.6 ± 11.7 | 84.3 ± 14.2 | 3.6 ± 3.2 | 16.7 ± 7.1 | 42.3 ± 14.8 | 37.6 ± 21.3 | 78.9 ± 15.5 | 93.3 ± 7.5 | 95.9 ± 1.1 | |
| All | 15 | 69.8 ± 19.2 | 18.5 ± 19.2 | 85.9 ± 10.8 | 3.8 ± 4.6 | 20.6 ± 16.7 | 40.9 ± 12.7 | 33.9 ± 20.4 | 76.6 ± 20.9 | 93.6 ± 7.3 | 96 ± 1.3 | |
| NH15 | Women | 7m | 83.6 ± 4.9 | 6.1 ± 3.2 | 89.4 ± 3.9 | 2.4 ± 1.9 | 13.1 ± 4.9 | 57.2 ± 11.2 | 18.2 ± 12.6 | 90.8 ± 4.3 | 97 ± 2.2 | 87.7 ± 2.5** |
| Men | 6m | 60.8 ± 17.4 | 18.6 ± 15.9 | 82.5 ± 3.9 | 4.1 ± 1.8 | 26.9 ± 12.2 | 63.4 ± 11.1 | 9.7 ± 10.6* | 67.1 ± 19.2 | 91 ± 4.7 | 85.8 ± 2.9** | |
| All | 13 | 73.1 ± 16.7 | 11.9 ± 12.4 | 86.2 ± 5.2 | 3.2 ± 2 | 19.4 ± 11.2 | 60 ± 11.1** | 14.3 ± 12.1** | 79.8 ± 17.7 | 94.2 ± 4.6 | 86.8 ± 2.7** | |
| NH13 | Women | 8 | 62.6 ± 24.4 | 21.2 ± 20.7 | 79.1 ± 12.8 | 5 ± 7.2 | 20.7 ± 13.5 | 63.2 ± 13.2** | 11.6 ± 15.8* | 70.2 ± 26.5 | 88.8 ± 12.6 | 78.4 ± 3.8** |
| Men | 7 | 62.6 ± 18.7 | 23.9 ± 16.5 | 77.6 ± 22.9 | 5 ± 4.3 | 23.2 ± 18.6 | 53.4 ± 16.3 | 18.7 ± 18.1 | 69.9 ± 18.3 | 85.3 ± 17.2 | 73.1 ± 5.8**A | |
| All | 15 | 62.6 ± 21.1 | 22.4 ± 18.3 | 78.4 ± 17.5 | 5 ± 5.8 | 21.9 ± 15.5 | 58.6 ± 15** | 14.9 ± 16.7** | 70 ± 22.2 | 87.1 ± 14.5 | 75.9 ± 5.4** | |
mMissing data due to lack of sleep. TST, Total Sleep Time; WASO, Wake after Sleep Onset; SPT, Sleep Period Time; SOL, Sleep Onset Latency; SE, Sleep Efficiency; SpO2, Peripheral oxygen saturation. Data as mean ± SD. *p < 0.05, **p < 0.001 comparing with NN. A p = 0.012 comparing with women in the same condition (Linear Mixed Model).
FIGURE 3Peripheral oxygen saturation (SpO2) (A) and cortisol (B) and erythropoietin (EPO) (C) concentrations after a 90 min nap under normoxic (NN) and hypoxic conditions (NH15: FiO2 14.7, NH13: FiO2 12.5) in healthy men (n = 7) and women (n = 8). Data as mean ± SEM. *p < 0.05, **p < 0.001 (Linear Mixed Model). Frequency of high concentration of epinephrine and dopamine (D). Missing data due to blood specimen damage during processing.
FIGURE 4Apnea-Hypopnea Index (AHI) (A) and Periodic Breathing Index (PBI) (B) during a 90 min nap under normoxic (NN) and hypoxic conditions (NH15: FiO2 14.7, NH13: FiO2 12.5) in healthy men (n = 7) and women (n = 8).